Glaxo Gets OK to Expand Marketing of Inhaler Drug
ABC News GlaxoSmithKline plc says it has received U.S. approval to sell its once-a-day respiratory inhaler Breo Ellipta for a new use in asthma patients ages 18 and older. The expanded approval from the Food and Drug Administration will help Glaxo replace sales ... |
April 30, 2015 at 04:48PM | marketing - Google News
Glaxo Gets OK to Expand Marketing of Inhaler Drug - ABC News
marketing - Google News
Nenhum comentário:
Postar um comentário